1. 2022-RA-262-ESGO Predictors of oncologic outcome in recurrent cervical cancer patients receiving phase 1 cancer therapy. (20th October 2022) Authors: Son, Ji; Lin, Heather Y; Fu, Siqing; Dumbrava, Ecaterina E; Karp, Daniel D; Naing, Aung; Pant, Shubham; Piha-Paul, Sarina A; Rodon, Jordi; Subbiah, Vivek; Tsimberidou, Apostolia M; Yap, Timothy A; Frumovitz, Michael M; Jazaeri, Amir A; Ramirez, Pedro T; Westin, Shannon N; Yuan, Ying; Meric-Bernst... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 283 Safety and efficacy signals in the complete phase I study of live biotherapeutic MRx0518 in combination with pembrolizumab in patients refractory to immune checkpoint inhibitors (ICIs). (9th November 2020) Authors: Pant, Shubham; Shah, Amishi; Msaouel, Pavlos; Campbell, Matthew; Tu, Shi-Ming; Gao, Jianjun; Blumenschein, George; Mott, Frank; Le, Xiuning; Altan, Mehmet; Meric-Bernstam, Funda; Yap, Timothy; Subbiah, Vivek; Rodon, Jordi; Glasmacher, Axel; Mulder, Imke; Chisamore, Michael; Stevenson, Alexander; ... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 374 A first-in-human Phase 1/2 open label trial evaluating the safety, pharmacology, and preliminary efficacy of VT1021 in subjects with advanced solid tumors. (10th December 2020) Authors: Mahalingam, Devalingam; Harb, Wael; Patnaik, Amita; Ulahannan, Susanna; Mahdi, Haider; Ahluwalia, Manmeet; Patel, Manish; Dowlati, Afshin; Bullock, Andrea; Wen, Patrick; Pant, Shubham; Mulcahy, Mary; Guttendorf, Robert; Vaickus, Lou; Wang, Suming; Crochiere, Marsha; Vincent, Melanie; Cieslewicz, ... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 374 A first-in-human Phase 1/2 open label trial evaluating the safety, pharmacology, and preliminary efficacy of VT1021 in subjects with advanced solid tumors. (9th November 2020) Authors: Mahalingam, Devalingam; Harb, Wael; Patnaik, Amita; Ulahannan, Susanna; Mahdi, Haider; Ahluwalia, Manmeet; Patel, Manish; Dowlati, Afshin; Bullock, Andrea; Wen, Patrick; Pant, Shubham; Mulcahy, Mary; Guttendorf, Robert; Vaickus, Lou; Wang, Suming; Crochiere, Marsha; Vincent, Melanie; Cieslewicz, ... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 376 A phase I/II study of live biotherapeutic MRx0518 in combination with pembrolizumab in patients refractory to immune checkpoint inhibitors. (9th November 2020) Authors: Pant, Shubham; Shah, Amishi; Msaouel, Pavlos; Campbell, Matthew; Tu, Shi-Ming; Gao, Jianjun; Blumenschein, George; Mott, Frank; Le, Xiuning; Altan, Mehmet; Meric-Bernstam, Funda; Yap, Timothy; Subbiah, Vivek; Rodon, Jordi; Glasmacher, Axel; Mulder, Imke; Chisamore, Michael; Stevenson, Alexander; ... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A229 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 407 Preliminary safety, pharmacokinetics/pharmacodynamics, and antitumor activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors. (10th December 2020) Authors: Shum, Elaine; Daud, Adil; Reilley, Matthew; Najjar, Yana; Thompson, John; Baranda, Joaquina; Donald Harvey, R; Leidner, Rom; Shields, Anthony; Cohen, Ezra; Cohen, Roger; Mita, Alain; Pant, Shubham; Stein, Mark; Chmielowski, Bartosz; Hu-Lieskovan, Siwen; Fleener, Catherine; Ding, Ying; Chollate, S... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 407 Preliminary safety, pharmacokinetics/pharmacodynamics, and antitumor activity of XmAb20717, a PD-1 x CTLA-4 bispecific antibody, in patients with advanced solid tumors. (9th November 2020) Authors: Shum, Elaine; Daud, Adil; Reilley, Matthew; Najjar, Yana; Thompson, John; Baranda, Joaquina; Donald Harvey, R; Leidner, Rom; Shields, Anthony; Cohen, Ezra; Cohen, Roger; Mita, Alain; Pant, Shubham; Stein, Mark; Chmielowski, Bartosz; Hu-Lieskovan, Siwen; Fleener, Catherine; Ding, Ying; Chollate, S... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗